ICCM — IceCure Medical Ltd.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1584371 ·
Israel
Last close
$1.73
Market Cap
$5.93M
52W High
$42.00
52W Low
$1.65
ADV30
145,343
Next earnings
2026-11-18
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 907,000 | 253,000 | -4,424,000 | -4,501,000 | 17,707,000 | 12,034,000 | 5,811,000 |
| Mar 2026 | 911,000 | 295,000 | -4,247,000 | -4,274,000 | 13,303,000 | 8,115,000 | 4,809,000 |
| Dec 2025 | 1,279,000 | 600,000 | -4,216,000 | -4,246,000 | 13,888,000 | 8,897,000 | 4,837,000 |
| Sep 2025 | 850,000 | 277,000 | -3,836,000 | -3,859,000 | 15,078,000 | 4,971,000 | 5,772,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-14,806,000
Investing CF
$-82,000
Financing CF
$16,809,000
CapEx
$-81,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.60
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-124,710,000
Inventory
$2,646,000
Receivables
$1,363,000
ST Investments
$5,034,000
EBIT TTM
$-15,684,000
Pretax Income TTM
$-15,743,000
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,947,000
EBITDA
$-16,439,000
Free Cash Flow
$-9,538,000
Enterprise Value
$-4,370,960
Total Cash
$12,034,000
Total Debt
$90,000
Shares Out
3,426,715
Trailing EPS
$-6.78
Book Value
$3.47
ROE
-228.3%
ROA
-73.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 3,379,000 | -15,094,000 | -15,057,000 | 13,888,000 | 4,837,000 | 9,051,000 | -14,574,000 |
| Dec 2024 | 3,291,000 | -15,696,000 | -15,318,000 | 12,576,000 | 5,675,000 | 6,901,000 | -12,563,000 |
| Dec 2023 | 3,229,000 | -15,576,000 | -14,652,000 | 16,410,000 | 4,247,000 | 12,163,000 | -12,550,000 |
| Dec 2022 | 3,085,000 | -16,739,000 | -16,978,000 | 30,188,000 | 4,766,000 | 25,422,000 | -14,292,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-3.31
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MHUAF | Meihua International Medical Technologies Co., Ltd. | $5.99M | $7.00 | — |
| NVNO | enVVeno Medical Corp | $6.02M | $8.67 | — |
| SNOA | Sonoma Pharmaceuticals, Inc. | $6.08M | $1.27 | — |
| INBS | INTELLIGENT BIO SOLUTIONS INC. | $5.15M | $1.70 | — |
| USAQ | QHSLab, Inc. | $4.81M | $0.32 | — |
News headlines (Yahoo Finance, 1h cache)
IceCure Medical Receives Regulatory Approval to Market ProSense® in China
2026-09-10 11:58 · Yahoo
IceCure Signs Exclusive Distribution Agreement for ProSense® Cryoablation Systems in the Netherlands
2026-08-24 11:50 · Yahoo
Icecure Medical Ltd (ICCM) (Q2 2026) Earnings Call Highlights: Revenue Surges 45% as US ...
2026-08-20 03:01 · Yahoo
IceCure Medical (ICCM) Q2 2026 Earnings Call Transcript
2026-08-19 15:43 · Yahoo
IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation
2026-08-13 13:10 · Yahoo
IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year
2026-08-12 12:30 · Yahoo
IceCure Medical to Report First Half 2026 Financial and Operating Results on August 12, 2026
2026-08-05 12:30 · Yahoo
IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site
2026-07-27 12:32 · Yahoo
IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation
2026-07-14 12:32 · Yahoo
IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer
2026-07-06 12:11 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.